Tyra biosciences to present at upcoming investor conferences

Carlsbad, calif. , feb. 11, 2025 /prnewswire/ -- tyra biosciences, inc. (nasdaq: tyra), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in fibroblast growth factor receptor (fgfr) biology, today announced that company management will participate in the following investor conferences: oppenheimer 35th annual healthcare life sciences conference, february 11-12, 2025 format: fireside chat and one-on-one investor meetings presentation date/time: wednesday, february 12, 2025, at 2:00 pm et location: virtual td cowen 45th annual healthcare conference, march 3-5, 2025 format: fireside chat and one-on-one investor meetings presentation date/time: monday, march 3, 2025, at 9:50 am et location: boston jefferies biotech on the beach summit, march 11-12, 2025 format: one-on-one investor meetings location: miami barclays 27th annual global healthcare conference, march 11-13, 2025 format: fireside chat and one-on-one investor meetings presentation date/time: wednesday, march 12, 2025, at 8:30 am et location: miami a live and archived webcast of the fireside chats will be available via the  for investors  page on the investor section of the tyra website.
TYRA Ratings Summary
TYRA Quant Ranking